Chronic hepatitis C virus infection,mixed cryoglobulinaemia,leukocytoclastic vasculitis and antineutrophil cytoplasmic antibodies

Durand JM et al. Cutaneous vasculitis and cryoglobulinemia type II associated with hepatitis C virus infection. Lancet 1991 ; 337: 499-500.

Wamy M. et al. Antineutrophil antibodies in chronic hepatitis C and effect of alpha interferon therapy. J Hepatol 1993 ; 17: 294-300.

Cid CM New developments in the pathogenesis of systemic vasculitis. Curr Opin Rheumatol 1996; 8: 1-11.

Foucher P. et al. In vivo lung perfusion of activated neutrophil products in myeloperoxidase immunized rats. Clin Exp Immunol 1995, 111 (Suppl.): 40.

Tomer Y. et al. Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice: pathogenetic role in experimental vasculitis. Arthritis Rheum 1995; 38: 1375—1381.

Daoud MS et al. Cutaneous Wegener's granulomatosis: clinical, histopathologic and immunopathologic features of thirty patients. J Am Acad Dermatol 1994; 31: 605—612.

Falk RJ et al. Antineutrophil cytoplasm autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci 1990; 87: 4115—4119.

Savage C. et al. Myeloperoxidase binds to vascular endothelial cells, is recognized by ANCA and can enhance complement dependent cytotoxicity. In: Gross WL (ed). ANCA-associated Vasculitides . Plenum Press: New York and London 1993, pp. 121—123.

Kings WS et al. Endothelial and epithelial expression of proteinase 3, the autoantigen for cANCA. Clin Exp Immunol 1995; 111(Suppl.): 37.